HGBC, a user-oriented genomic data ecosystem engaging researchers and service providers, has been fully integrated and deployed on ThunderChain – which is an open blockchain platform built by cloud company Xunlei. HGBC completes its business deployment including data storage, integration, cochain proof of ownership and token distribution on the ThunderChain.
The successful launch of HGBC marks a key step as ThunderChain’s support for third-party applications. Handling millions of transactions per second (TPS), it allows a block to be generated within seconds on a single chain. ThunderChain is based on Xunlei’s proprietary homogeneous multichain framework, which can realize confirmation and interaction among homogeneous chains and enable multiple transactions to be executed on different chains in parallel. The platform also supports smart contracts coded with Solidity, and is compatible with Ethereum Virtual Machine (EVM), enabling migration across multiple blockchain platforms.
The ThunderChain File System (TCFS) launched at the beginning of July is a decentralized file system dedicated to the cloud-based data storage and authorized distribution over blockchain.
TCFS provides applications with distributed storage and blockchain integration of data, thereby enabling applications to possess openness, transparency, tamper-proof, traceability, reliability, security encryption, mass storage and authorization transfer.
Neil Wasserman, an adjunct professor at George Washington University, who is positive about blockchain applications in healthcare and other areas, commented that the ThunderChain is one of several that addressed the transaction and application problem. “The ThunderChain design is able to radically increase the transaction rate, but more importantly, provide a very flexible architecture for how you organize the chain in relation to the business environment.”
HGBC, one of first ThunderChain applications, can lead to higher productivity and cheaper data access of researchers, when compared to traditional, highly centralized databases.
Today, over 10 million people have taken gene test, with approximately 1 billion predicted to do so in the next eight years. The enormous amount of data poses a series of challenges including storage, adoption and security.
For example, individual users cannot oversee the adoption of their genetic data. Some sequencing companies even declare to users that these companies are the sole beneficiaries of any value that genetic data may generate from research and business activities and users will have nothing to do with it.
In response to privacy and security concerns, HGBC integrates genetic information and other big data such as exercise records, health examination reports and physical periods onto the blockchain and authenticates their ownership. Users can take part in research programs to gain credits that may be used to redeem services of genetic applications.
The middlemen will not be needed from the process and the sequencing costs are saved with greater efficiency in user communications. It can thereby help research companies produce new drugs and research results more quickly. Moreover, the genomic services can be improved on a timely basis thanks to immediate feedback from users.